Akt2 on the other hand was shown to interact with Prohibitin 2/Repressor of Estrogctivator (PHB2/REA) which has been implicated in transcriptional repression of myogenesis in estrogen-dependent cancers like breast cancer [104,105]. Here, AKT2 is linked to breast cancer.